Scott Mendel - 02 Oct 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Scott Mendel, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
02 Oct 2024
Net transactions value
$0
Form type
4
Filing time
04 Oct 2024, 18:44:38 UTC
Previous filing
05 Jun 2024
Next filing
21 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Stock Option (right to buy) Award $0 +44,959 $0.000000 44,959 02 Oct 2024 Common Stock 44,959 $2.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuous service through the vesting dates, the options shall vest ratably on a quarterly basis over four quarters, with the first vesting date to occur on January 1, 2025.